MX2020009004A - Derivados de acido nucleico bloqueado-acido dicarboxilico y proceso para su preparacion. - Google Patents
Derivados de acido nucleico bloqueado-acido dicarboxilico y proceso para su preparacion.Info
- Publication number
- MX2020009004A MX2020009004A MX2020009004A MX2020009004A MX2020009004A MX 2020009004 A MX2020009004 A MX 2020009004A MX 2020009004 A MX2020009004 A MX 2020009004A MX 2020009004 A MX2020009004 A MX 2020009004A MX 2020009004 A MX2020009004 A MX 2020009004A
- Authority
- MX
- Mexico
- Prior art keywords
- dicarboxylic acid
- lna
- acid derivatives
- sup
- preparation
- Prior art date
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000002515 oligonucleotide synthesis Methods 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención comprende derivados de ANB-ácido dicarboxílico de fórmula I o sales de los mismos, en donde R1 es una nucleobase o una nucleobase modificada, R2 es un grupo protector de hidroxilo y n es un número entero de 1 a 5. Los derivados de ANB-ácido dicarboxílico de la fórmula I se pueden usar en soportes sólidos precargados de la fórmula III y que sirven como material de partida adecuado para la síntesis de oligonucleótidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18161687 | 2018-03-14 | ||
PCT/EP2019/056068 WO2019175126A1 (en) | 2018-03-14 | 2019-03-12 | Lna-dicarboxylic acid derivatives and process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020009004A true MX2020009004A (es) | 2020-10-05 |
Family
ID=61655630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020009004A MX2020009004A (es) | 2018-03-14 | 2019-03-12 | Derivados de acido nucleico bloqueado-acido dicarboxilico y proceso para su preparacion. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20200407392A1 (es) |
EP (1) | EP3765473A1 (es) |
JP (1) | JP2021516673A (es) |
KR (1) | KR20200131232A (es) |
CN (1) | CN111836822A (es) |
AU (1) | AU2019235331A1 (es) |
BR (1) | BR112020014494A2 (es) |
CA (1) | CA3092235A1 (es) |
IL (1) | IL277066B2 (es) |
MX (1) | MX2020009004A (es) |
SG (1) | SG11202008232QA (es) |
WO (1) | WO2019175126A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018215049A1 (en) | 2017-05-23 | 2018-11-29 | F. Hoffmann-La Roche Ag | Process for galnac oligonucleotide conjugates |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9021625D0 (en) | 1990-10-04 | 1990-11-21 | Ici Plc | Synthesis of oligonucleotides |
US20040033973A1 (en) * | 2002-08-16 | 2004-02-19 | Muthiah Manoharan | Compounds and oligomeric compounds comprising novel nucleobases |
DK2708541T3 (en) | 2003-11-13 | 2015-02-23 | Isis Pharmaceuticals Inc | 5,6-dihydroxy-isoindole derivatives as linkers for oligomeric solid phase synthesis |
WO2006029023A2 (en) | 2004-09-02 | 2006-03-16 | Isis Pharmaceuticals, Inc. | Polymeric beads for oligonucleotide synthesis |
US8541569B2 (en) * | 2008-09-06 | 2013-09-24 | Chemgenes Corporation | Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA |
JP6237237B2 (ja) * | 2012-02-17 | 2017-11-29 | 味の素株式会社 | 塩基部保護オリゴヌクレオチド |
EP4219516A3 (en) * | 2012-07-13 | 2024-01-10 | Wave Life Sciences Ltd. | Chiral control |
JP6429264B2 (ja) * | 2013-11-12 | 2018-11-28 | 学校法人東京理科大学 | ボラノホスフェート化合物、及び核酸オリゴマー |
-
2019
- 2019-03-12 CN CN201980017513.4A patent/CN111836822A/zh active Pending
- 2019-03-12 EP EP19709946.8A patent/EP3765473A1/en active Pending
- 2019-03-12 BR BR112020014494-0A patent/BR112020014494A2/pt unknown
- 2019-03-12 AU AU2019235331A patent/AU2019235331A1/en active Pending
- 2019-03-12 JP JP2020544011A patent/JP2021516673A/ja active Pending
- 2019-03-12 CA CA3092235A patent/CA3092235A1/en active Pending
- 2019-03-12 SG SG11202008232QA patent/SG11202008232QA/en unknown
- 2019-03-12 MX MX2020009004A patent/MX2020009004A/es unknown
- 2019-03-12 WO PCT/EP2019/056068 patent/WO2019175126A1/en unknown
- 2019-03-12 KR KR1020207025494A patent/KR20200131232A/ko active Search and Examination
- 2019-03-12 IL IL277066A patent/IL277066B2/en unknown
-
2020
- 2020-09-10 US US17/016,592 patent/US20200407392A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL277066B2 (en) | 2023-09-01 |
AU2019235331A1 (en) | 2020-08-06 |
US20200407392A1 (en) | 2020-12-31 |
JP2021516673A (ja) | 2021-07-08 |
EP3765473A1 (en) | 2021-01-20 |
BR112020014494A2 (pt) | 2020-12-01 |
IL277066A (en) | 2020-10-29 |
WO2019175126A1 (en) | 2019-09-19 |
CN111836822A (zh) | 2020-10-27 |
SG11202008232QA (en) | 2020-09-29 |
IL277066B1 (en) | 2023-05-01 |
KR20200131232A (ko) | 2020-11-23 |
CA3092235A1 (en) | 2019-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022008066A (es) | Compuestos triciclicos sustituidos. | |
MX2022006475A (es) | Compuestos triciclicos sustituidos. | |
MX2021013075A (es) | Oxisteroles y metodos de uso de los mismos. | |
TN2016000529A1 (en) | Substituted dihydroisoquinolinone compounds | |
MX2016017030A (es) | Inhibidores de cinasa de interaccion con proteina cinasa activada por mitogeno (mnk) y metodos relacionados con los mismos. | |
PH12017502331A1 (en) | 1,4-substituted piperidine derivatives | |
MX2021005052A (es) | Oxiesteroles y métodos de uso de los mismos. | |
MX2019013561A (es) | Compuestos de pirrolopiridina-anilina para el tratamiento de trastornos dermicos. | |
MX2018014164A (es) | Intermedios para la sintesis de derivados de acido biliar, en particular, de acido obeticolico. | |
MX2020009062A (es) | Piperidinil-3-(ariloxi)propanamidas y propanoatos. | |
MX2018007129A (es) | Formas solidas de ester etilico del acido (2r,4s)-5-(bifenil-4-il) -4-[(3-carboxipropionil)amino]-2-metil-pentanoico, sus sales y un metodo de preparacion. | |
CR20200413A (es) | Inhibidores de canal de potencial de receptor transitorio de oxadiazol | |
PH12019550140A1 (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
RU2016137668A (ru) | Новые производные каннабидиол-хинона | |
WO2018201167A3 (en) | Propionic acid derivatives and methods of use thereof | |
SG11201906688VA (en) | Novel ester compounds, method for the production thereof and use thereof | |
MX2022013401A (es) | Compuestos de azalactama como inhibidores de hpk1. | |
MX2022000550A (es) | Imidazopirimidinas como inhibidores de eed y uso de estas. | |
SG10201806809QA (en) | 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders | |
TN2017000485A1 (en) | Tricyclic compounds and their use as phosphodiesterase inhibitors | |
RU2007136782A (ru) | Ингибирующие вич 2-(4-цианофенил)-6-гидроксиламинопиримидины | |
TN2016000459A1 (en) | Cycloalkyl-linked diheterocycle derivatives. | |
TN2017000342A1 (en) | Novel cyclopropabenzofuranyl pyridopyrazinediones | |
MX2019006920A (es) | Derivados de la espiropiperidina. | |
MX2021001804A (es) | Compuestos de urea y composiciones como inhibidores de atpasa de smarca2/brm. |